Organic Chemistry
Click Chemistry
Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) — Sharpless coined term 2001, Nobel 2022
Click chemistry is K. Barry Sharpless's 2001 design philosophy for high-yielding, modular, near-quantitative reactions. Its flagship is the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) — a roughly 10⁷-fold rate enhancement over the thermal Huisgen reaction, generating 1,4-disubstituted 1,2,3-triazoles regioselectively in water at room temperature. Sharpless and Morten Meldal independently discovered CuAAC in 2001-2002, and they shared the 2022 Nobel Prize with Carolyn Bertozzi, who extended click into living cells with strain-promoted azide-alkyne cycloaddition (SPAAC) using cyclooctynes. Click is now the default tool for bioconjugation, antibody-drug conjugates, and surface functionalization.
- Term coinedSharpless 2001
- Nobel2022 (Sharpless, Meldal, Bertozzi)
- Rate enhancement~10⁷ vs thermal Huisgen
- Product1,4-disubstituted 1,2,3-triazole
- SolventWater (often)
- Activation barrier~14 kcal/mol (vs ~26 thermal)
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why click chemistry matters
- Near-quantitative under mild conditions. CuAAC routinely achieves >95% yield in water at room temperature in 1 to 60 minutes. The thermodynamic driving force for triazole formation from azide + alkyne is ~30 kcal/mol — the bond is so favorable that side reactions effectively do not happen.
- Bioorthogonal — works in living cells. Bertozzi's SPAAC reagents (DBCO, BCN, DIBO cyclooctynes) react with azides in vivo with no copper, no toxicity, and no cross-reactivity with the ~10,000 native biomolecules in a cell. This is how researchers track glycans on cell surfaces, image protein dynamics in zebrafish embryos, and deliver drugs in mice.
- Antibody-drug conjugates (ADCs). ~30 clinical-stage ADCs use click linkers. Polivy (polatuzumab vedotin, Roche) for diffuse large B-cell lymphoma uses an MMAE-cleavable linker installed by click. Average ADC drug-antibody ratio (DAR) ~3.5 with click vs ~2.0 with maleimide chemistry — better homogeneity means better PK and FDA approvability.
- In situ drug discovery. Sharpless's "in situ click" — the enzyme acts as a template, assembling its own inhibitor from azide and alkyne fragments under physiological conditions. TZ2PA6, a femtomolar acetylcholinesterase inhibitor, was discovered by mixing 49 azides + 49 alkynes in the presence of AChE and seeing which combinations the enzyme catalyzed.
- Industrial-scale ADC manufacture. SPAAC and CuAAC both run at multi-kilogram scale at companies like Synthon, Lonza, and Sutro Biopharma. Reaction is tolerant of buffers, salts, denaturants, and protein concentrations >50 mg/mL — no other bioconjugation chemistry matches this combination.
- 10,000+ papers per year. Click chemistry was cited in over 10,000 papers in 2022, the year of the Nobel. The terms "click chemistry" or "CuAAC" appear in roughly 1 in 200 chemistry papers — comparable to "Suzuki coupling" in pharma or "Diels-Alder" in total synthesis.
- Polymer post-functionalization. Polymers bearing pendant azides or alkynes can be decorated after polymerization with dyes, drugs, sugars, peptides, or crosslinks — this orthogonal functionalization is impossible with most other chemistries because polymerization conditions destroy reactive groups.
Common misconceptions
- Click means any easy reaction. No — Sharpless's six criteria are strict: high yield, no chromatography, benign solvent, modular, stereospecific, inoffensive byproducts. Many "easy" reactions (esterifications, amide couplings) fail at least one criterion. Only a handful of reactions are properly "click": CuAAC, SPAAC, thiol-ene, IEDDA tetrazine ligation, hydrazone/oxime formation.
- The thermal reaction also gives 1,4-triazoles. No — Huisgen's uncatalyzed reaction at 100+ °C gives ~1:1 mix of 1,4 and 1,5 regioisomers because the cycloaddition is concerted with no metal template. Cu(I) locks the regiochemistry to 1,4 because of the metallacycle geometry. Ru(II) catalysis (RuAAC) gives the opposite 1,5 isomer.
- Cu(I) is just a Lewis acid activating the alkyne. The Cu does not just activate — it covalently binds the terminal alkyne by losing the C-H proton, forming a Cu-acetylide that is the actual nucleophile. The C-N bonds form stepwise via a six-membered Cu-metallacycle, not concertedly.
- Azides are too dangerous to use. Inorganic azides (NaN3, HN3) are toxic, but organic azides are generally safe if the C/N ratio >3 by mass. Aryl azides, alkyl azides on long chains, and PEG-azides are routine reagents. The danger is low-MW azides like CH2N3-CH2N3 or sodium azide on metal surfaces (forms explosive heavy-metal azides).
- SPAAC is just slow CuAAC without copper. Mechanism is different — SPAAC is a concerted [3+2] cycloaddition driven by ~18 kcal/mol of cyclooctyne ring strain. Rate constants are 0.001 to 1 M⁻¹s⁻¹ depending on cyclooctyne — slower than CuAAC but still fast enough for live-cell work at micromolar concentrations.
- Triazoles are biologically inert. Mostly true — 1,2,3-triazoles are stable to acid, base, oxidants, and reducing agents at physiological conditions. But they are not entirely passive: the triazole ring acts as an amide bioisostere (similar dipole moment ~5 D, similar H-bond geometry), so triazole-containing drugs interact with proteins like amides do. Tazobactam and rufinamide are FDA-approved triazole drugs.
CuAAC mechanism
The CuAAC mechanism, established by DFT and kinetic studies from Fokin, Finn, and Houk between 2005 and 2013, requires two copper atoms and proceeds in three stages. First, Cu(I) coordinates the terminal alkyne RC≡CH; this lowers the alkyne C-H pKa from ~25 to ~15, allowing deprotonation by amine bases (DIPEA, Et3N, ascorbate) to form a Cu-acetylide RC≡C-Cu. Stage two is azide coordination: a second Cu(I) binds the proximal nitrogen of R'N3, activating the dipole. The two Cu-bound species converge into a six-membered Cu-metallacycle in which one new C-N bond has formed.
The metallacycle ring-contracts to a Cu-triazolide (a five-membered triazole still bound to Cu). Protonation of the Cu-triazolide releases the 1,4-disubstituted-1H-1,2,3-triazole product and regenerates Cu(I). The 1,4 regiochemistry comes from the metallacycle geometry — the alkyne carbon attached to R becomes C5 and the alkyne carbon attached to Cu becomes C4 of the triazole, placing R' on N1 and R on C4. This stepwise mechanism, with a calculated barrier of ~14 kcal/mol, is roughly 10⁷-fold faster than the concerted thermal Huisgen reaction (~26 kcal/mol).
The fastest practical conditions use CuSO4·5H2O (1 mol%) + sodium ascorbate (5 mol%) + tris(triazolylmethyl)amine ligand TBTA or BTTAA (1 mol%) in water or water/t-BuOH at room temperature. Ascorbate continuously reduces any Cu(II) back to Cu(I), and the polydentate triazolyl ligand protects Cu(I) from oxidation and disproportionation. Reactions complete in 1 to 60 minutes at millimolar concentrations. Workup is typically just dilution and extraction — no chromatography, matching Sharpless's "click" criterion of operational simplicity.
CuAAC vs SPAAC vs IEDDA vs RuAAC vs thiol-ene vs oxime
| Reaction | Partners | Catalyst | Rate constant (M⁻¹s⁻¹) | Bioorthogonal? | Discovered |
|---|---|---|---|---|---|
| CuAAC | Terminal alkyne + organic azide | Cu(I) (often + TBTA ligand) | 1 to 200 (with ligand) | No — Cu cytotoxic | Sharpless & Meldal 2001-2002 |
| SPAAC | Cyclooctyne + organic azide | None — strain-driven | 0.001 to 1 (DBCO faster) | Yes — gold standard for in vivo | Bertozzi 2004 (cyclooctyne); 2008 (DIBO) |
| IEDDA tetrazine | Tetrazine + trans-cyclooctene (TCO) | None — inverse electron demand | 10⁴ to 10⁶ (fastest known) | Yes — fast enough for low-µM imaging | Fox & Hilderbrand 2008 |
| RuAAC | Terminal or internal alkyne + azide | [Cp*RuCl] complexes | ~0.1 | No — Ru cytotoxic | Fokin 2005; gives 1,5-triazole |
| Thiol-ene | Thiol (RSH) + alkene | Radical initiator (UV or AIBN) | 10² to 10⁴ (anti-Markovnikov) | Limited — radicals damage DNA | Posner 1905; revived by Hawker 2008 |
| Hydrazone/oxime | Aldehyde + RNHNH2 or RONH2 | Aniline nucleophilic catalysis | 0.01 to 10 at pH 4-6 | Yes — but slow at pH 7.4 | Classical; Dawson 2006 aniline catalysis |
| Staudinger ligation | Phosphine + azide → amide | None — phosphine is reductant | ~0.001 to 0.01 | Yes — but slow and air-sensitive | Bertozzi & Saxon 2000 |
Famous applications
- Polivy / polatuzumab vedotin (Roche). Approved 2019 for relapsed diffuse large B-cell lymphoma, $1B+/yr. Anti-CD79b antibody linked to MMAE cytotoxin via a maleimide-PEG-valine-citrulline-PAB-MMAE click linker. Several next-generation ADCs in trials use SPAAC-installed linkers for better DAR uniformity.
- Bertozzi's glycan imaging in zebrafish. Feed embryos a peracetylated N-azidoacetylmannosamine, the cell's biosynthesis incorporates the azide into surface sialic acids, then add fluorophore-DBCO and watch glycans bloom on the developing fish in real time. This 2008 Science paper launched bioorthogonal chemistry as a discipline.
- In situ click — TZ2PA6. Sharpless mixed 49 acetylcholinesterase ligands with 49 azide partners in the presence of AChE; the enzyme template caused one specific pair to react ~1000x faster than off-target. The product TZ2PA6 is a 99-fM AChE inhibitor (potency rivaling natural neurotoxins) and is now a blueprint for fragment-based drug discovery.
- PET radiotracer ¹⁸F-AzPet labeling. ¹⁸F-fluoride decays with t₁/₂ = 110 min, so radiochemistry must finish in ~30 min. ¹⁸F-azide + DBCO-ligand on a peptide via SPAAC at room temperature in water completes in 5 to 10 minutes — has enabled clinical PET tracers for HER2, integrins, and PSMA cancer imaging.
- Industrial cell-culture surface coatings. Click reactions install RGD peptides, growth factors, or extracellular-matrix mimics onto plastic dishes for stem cell culture. Companies like Sigma-Aldrich and Corning sell click-functionalizable plasticware as a standard catalog item — a market that did not exist before 2005.
Frequently asked questions
What makes a reaction 'click' in Sharpless's definition?
Sharpless's 2001 paper defined click reactions by six criteria: modular and wide in scope, high-yielding (typically >85%), generate only inoffensive byproducts (water, salts, N2), stereospecific, simple to run (no chromatography, no inert atmosphere), and use readily available reagents and benign solvents (water or no solvent). Reactions that meet all six are rare — the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) is the canonical example. Other reactions in the 'click family' include thiol-ene radical addition, Diels-Alder with inverse electron demand, hydrazone and oxime formation, and the Staudinger ligation. The unifying theme is that the reaction has a thermodynamic driving force so large (~30 kcal/mol for triazole formation from azide + alkyne) that mistakes don't happen — the bond clicks shut.
How does Cu(I) accelerate the azide-alkyne cycloaddition?
Cu(I) coordinates to the terminal alkyne and lowers the pKa of the C-H by 10 units, enabling deprotonation under mild conditions to form a Cu-acetylide. The acetylide is the actual nucleophile in CuAAC — its azide attack is stepwise (via a six-membered metallacycle), not concerted as in the thermal Huisgen reaction. DFT calculations from Fokin and Houk showed two Cu atoms are involved in the active intermediate, with one Cu binding the alkyne and a second Cu binding the azide nitrogen. The activation barrier drops from ~26 kcal/mol (thermal, requires 100 °C and hours) to ~14 kcal/mol (Cu-catalyzed, runs at room temperature in minutes). Net rate enhancement is roughly 10⁷-fold and the regiochemistry is locked to 1,4 because of the metallacycle geometry.
Why is the thermal Huisgen reaction not click chemistry?
Rolf Huisgen developed the 1,3-dipolar cycloaddition between azides and alkynes in the 1960s, but the uncatalyzed reaction is slow (hours to days at 80-120 °C), gives a roughly 1:1 mixture of 1,4- and 1,5-disubstituted triazoles, and requires high concentrations. None of those properties match click criteria — the regiochemistry is poor, conditions are harsh, and the energy of activation is ~26 kcal/mol. The Sharpless/Meldal contribution in 2001-2002 was demonstrating that copper(I) catalysis lifts all three problems simultaneously. The thermal reaction is still useful in a few contexts where regiochemistry doesn't matter (polymer crosslinking, statistical labeling), but it is not click.
What is bioorthogonal chemistry and how does SPAAC work?
Bioorthogonal chemistry is Carolyn Bertozzi's term for reactions that proceed selectively inside living cells without interfering with native biochemistry. Cu(I) is cytotoxic at the concentrations needed for CuAAC (~mM Cu ions damage DNA via Fenton chemistry), so Bertozzi developed strain-promoted azide-alkyne cycloaddition (SPAAC) using cyclooctyne — a strained eight-membered alkyne whose ~18 kcal/mol of ring strain provides the kinetic activation that copper provides in CuAAC. Cyclooctyne reacts with azides at room temperature in water without catalyst at rates of 0.001 to 1 M⁻¹s⁻¹ depending on substituents. DIBO, BCN, and DBCO (dibenzocyclooctyne) are the most-used reagents — they enable in vivo imaging, glycan labeling, and antibody-drug conjugates. Bertozzi shared the 2022 Nobel for this work.
What are real industrial and research uses of click chemistry?
Click chemistry is now standard in five major application areas. Bioconjugation: antibody-drug conjugates (ADCs) like Polivy (Roche) attach cytotoxic payloads via click linkers; ~30 ADCs in clinical trials use click chemistry. Drug discovery: in situ click — Sharpless's technique where the enzyme template assembles its own inhibitor from azide and alkyne fragments — produced TZ2PA6, a femtomolar inhibitor of acetylcholinesterase. Materials: dendrimers, hydrogels, and surface coatings (cell-culture plates, biosensors) use click for orthogonal coupling. Polymer chemistry: post-polymerization functionalization to install dyes, drugs, or crosslinks. Imaging: PET tracers built from ¹⁸F-azides use SPAAC for site-specific radiolabeling at room temperature in water. The number of click chemistry papers per year exceeded 10,000 by 2022.
What are common pitfalls when running CuAAC?
Three big ones. First, copper oxidation: Cu(I) is air-sensitive and oxidizes to inactive Cu(II), so most protocols generate Cu(I) in situ from CuSO4 + sodium ascorbate (the ascorbate reduces Cu(II) to Cu(I) and keeps it there). Second, ligand selection: tris(triazolylmethyl)amines like TBTA or BTTAA accelerate CuAAC by 10-100x and protect Cu(I) from oxidation; bare CuI in DMSO works but is slow and gives variable yields. Third, azide handling: low-MW organic azides are explosive (the rule of thumb is the C/N ratio must exceed ~3:1), so use only aryl azides, larger alkyl azides, or generate azides in situ from NaN3 + RX. Working in water is fine and often preferred — CuAAC is faster in water than in organic solvents because of hydrophobic association of the alkyne and azide partners.